Supernus Pharmaceuticals reported $1.69B in Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Ani Pharmaceuticals ANIP:US USD 739.11M 12.22M
Aurora Cannabis Inc ACB:CN CAD 1.17B 85.57M
Bristol Myers Squibb BMY:US USD 98.2B 2.16B
Canopy Growth Corp WEED:CN CAD 3.4B 115.26M
Cara Therapeutics CARA:US USD 213.51M 13.06M
Corcept Therapeutics CORT:US USD 533.26M 36.89M
Eisai 4523:JP JPY 1.26T 11.59B
Eli Lilly And LLY:US USD 47.46B 397.9M
Endo International Ordinary Shares ENDP:US USD 6.01B 355.8M
Horizon Pharma HZNP:US USD 9.03B 174.39M
Lannett LCI:US USD 467.3M 17.14M
Marinus Pharmaceuticals MRNS:US USD 184.84M 75.46M
Pacira Pharmaceuticals PCRX:US USD 1.73B 377K
Perrigo Ordinary Shares PRGO:US USD 10.68B 242.1M
Revance Therapeutics RVNC:US USD 711.59M 149.71M
Supernus Pharmaceuticals SUPN:US USD 1.69B 1.84M
Teva Pharmaceutical Industries TEVA:US USD 44.25B 1.68B
United Therapeutics UTHR:US USD 5.78B 238.3M
Xeris Pharmaceuticals Inc XERS:US USD 303.02M 15.6M